AI-generated summary
The authors studied 16 adults with type 2 diabetes who received light-emitting diode therapy or a placebo before moderate cycling exercise in a randomized, crossover design. They report that light-emitting diode therapy was associated with lower glucose levels after exercise, while cardiopulmonary responses and lactate levels did not differ between groups. The sample was small and the abstract reports only acute effects.
- Participants
- 16
- Who or what was studied
- Adults with type 2 diabetes mellitus (men, mean age 55.1 years)
- Wavelengths
- 850 nm
- Limits stated in the abstract
- Small sample of 16 participants, and the study reports only acute effects measured in a single session.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 850nm
- Power
- 75mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.